Insider Transactions in Q3 2024 at Ab Cellera Biologics Inc. (ABCL)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2024
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+6.25%
|
$112,250
$2.7 P/Share
|
|
Aug 29
2024
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
283,516
+0.5%
|
$567,032
$2.61 P/Share
|